CME Group Inc. 8-K Summary: 2025 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of CME Group Inc.'s 2025 Annual Meeting of Shareholders held on May 8, 2025. The record date for the meeting was March 10, 2025, with 360,382,710 shares of Class A and Class B common stock issued and outstanding. A total of 311,658,709 shares (86.47%) were present in person or by proxy.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Voting Results
The following proposals were submitted to a vote of security holders:
- Election of Equity Directors: All fourteen nominees for Equity Directors were elected to serve until 2026. Notable voting patterns included significant "Against" votes for Phyllis M. Lockett (111,549,878 votes against) and Martin J. Gepsman (42,487,931 votes against).
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent public accounting firm for 2025 was ratified with 289,994,511 votes in favor.
- Executive Compensation Advisory Vote: The advisory vote on named executive officer compensation was approved with 251,216,946 votes in favor.
- Election of Class B Directors: No quorum was achieved for the election of Class B-1, Class B-2, and Class B-3 directors. Consequently, incumbent directors William W. Hobert, Patrick J. Mulchrone, Robert J. Tierney Jr., Patrick W. Maloney, and Elizabeth A. Cook are serving as "holdover" directors under Delaware law and the Company's bylaws until their successors are elected or they resign. A vacancy exists in one Class B-2 director position.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting results and the holdover status of certain directors due to a lack of quorum.
Key Facts for Investor Verification
- Verify the specific reasons for the lack of quorum in the Class B director elections and the timeline for filling the vacancy in the Class B-2 position.
- Review the proxy statement for details on the significant "Against" votes cast for specific Equity Director nominees.
- Confirm the continued service of holdover directors and their impact on board composition until the 2026 Annual Meeting.